Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease ...

Swiss drugmaker Roche Holding plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high ...

Swiss pharmaceutical giant Roche is set to explore the potential of its experimental drug, Trontinemab, in delaying or ...

Swiss pharma major Roche (ROG: SIX) has outlined ambitious plans to accelerate the development of trontinemab, its ...

The drugmaker’s sales were up 7% at constant currency from the same period last year.

Swiss pharmaceutical company Roche is launching a study to test a new drug that could prevent Alzheimer's in high-risk ...

Roche’s move came against a backdrop of wider industry retreat from gene therapy, with Pfizer pulling its FDA-approved ...

To Roche’s advantage, demand still outstrips the supply of such drugs—and as the market continues to grow in more countries, the Swiss giant could have a shot at success after all.

Business Swiss pharmaceuticals company Roche announces $50B investment in US over next 5 years The logo of the pharmaceutical company Roche pictured in Basel, Switzerland, on Feb. 1, 2017.

Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer’s disease symptoms in high-risk people, ...

GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Monday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs.